Home » Topics » BioWorld Science

BioWorld Science
RSS

Ad26.COV2.S vaccine provides robust protection against SARS-CoV-2 in rhesus macaques

Aug. 14, 2020

Debiopharm presents 3-year follow-up data from phase II study of Debio-1143

Aug. 14, 2020

Clinical improvement seen with anti-MASP-2 monoclonal antibody narsoplimab in COVID-19 patients

Aug. 14, 2020

First patient recruited in phase II study of ASN-002 in combination with vismodegib

Aug. 14, 2020

Healx enters a new partnership to accelerate development of therapeutics for Angelman Syndrome

Aug. 14, 2020

Theralase re-initiates phase II study of TLD-1433 in Canada

Aug. 14, 2020

New PTP-2C inhibitors disclosed by Betta Pharmaceuticals

Aug. 14, 2020

Jiangsu Chia Tai Tianqing Pharmaceutical Group presents AKT inhibitors

Aug. 14, 2020

Exelixis synthesizes new AXL and/or MERTK inhibitors

Aug. 14, 2020

SCO-267 improves liver parameters in a mouse model of NAFLD

Aug. 14, 2020

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...